All anti-CD20 therapies are equivalent in treating MS-YES

Authors

• Dilraj Sokhi, Aga Khan UniversityFollow
• Deanna Saylor, University of North Carolina, USA

Document Type

Article

Department

Internal Medicine (East Africa)

Publication (Name of Journal)

Nature reviews. Neurology

DOI

https://doi.org/10.1177/13524585261466516

Recommended Citation

Sokhi, D., Saylor, D. (2026). All anti-CD20 therapies are equivalent in treating MS-YES. Nature reviews. Neurology, 1-3.
Available at: https://ecommons.aku.edu/eastafrica_fhs_mc_intern_med/621